Taken together, this data suggests that in some patients with FLT3-ITD+ AML, the homeostasis of bone marrow cDCs is disrupted and is characterized by a previously unreported expansion of double-negative XCR1-cDC1- poorly-differentiated cDCs. This evidence concerns the gene FLT3 and acute myeloid leukemia.